Mouse SimpleStep ELISA Kits

Mouse SimpleStep ELISA Kits

June 12, 2015

ELISA kits to mouse targets may be less reproducible, specific and sensitive when compared to ELISA kits to other species’ targets due to the use of batch-specific polyclonal antibodies. Use of monoclonal antibodies in ELISA is preferred for target specificity and reproducibility; however, mouse monoclonal antibodies cannot be generated to mouse targets and the use of related rodent hosts, such as rat are difficult to produce.

Many SimpleStep ELISA kits to mouse targets use RabMAb antibody technology, Abcam’s patented rabbit monoclonal technology, to achieve greater sensitivity and specificity. Rabbit monoclonal antibodies have the enhanced affinity of a rabbit host antibody coupled with the specificity that is the hallmark of monoclonal antibodies. In addition, a majority of RabMAb antibodies are recombinant monoclonal antibodies delivering more batch-to-batch consistency in quality and performance.  Multiple rabbit monoclonal antibodies are screened for optimal performance as both capture and detector antibodies before selection for SimpleStep ELISA Kits.  As a result, these ELISA kits frequently exhibit improved assay performance with greater sensitivity than the leading competitors.

In addition to improvements in sensitivity, SimpleStep ELISA kits offers multiple benefits to the researcher:
-    90 minute assay time with no wash step reduces time to results from the standard 4+ hours
-    Validated with relevant matrices so that they will work in complex samples
-    Broad dynamic range reduces the need for multiple sample dilutions

Get the best ELISA kits for your research from Abcam!

Get the best ELISA kits for your research from Abcam!

​Choose from over 2,000 ELISA kits covering 1,000 specific targets in over 18 species including human, mouse and rat. From cytokines to popular cancer-related targets like PD-L1, from immunology to neuroscience, find from Abcam the ELISA kit you need for your research!

 

April 18, 2019 More +
New MASTR Facility supports adoption of NGS

New MASTR Facility supports adoption of NGS

Multiplicom is pleased to announce the new MASTR Facility to enable the implementation of massively parallel sequencing capabilities in clinical genetics and pathology laboratories.

September 15, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us